|
|
[ÇóÖú]
ÇóһƪÎÄÏ×µÄÆÚºÅ
|
ËÖªµÀJ. Pharm. Biomed. AnalÔÓÖ¾µÄ¾íºÅºÍÆÚºÅÊÇÔõô±àÅŵÄ,Stability-indicating UPLC Method for Determination of Imatinib Mesylate and Their Degradation Products in Active Pharmaceutical Ingredient and Pharmaceutical Dosage Forms2012£¬66£¨£©: 109-115ÔõôҲÕÒ²»µ½ÆÚºÅ£¬µ«ÔÓÖ¾ÖÐÆäËûÎÄÏ×È´ÄÜÕÒµ½¡£¼±£¬Âé·³´ó¼Ò°ïæ¡£ |
» ²ÂÄãϲ»¶
ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O54,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ7È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.551.O.5.4,¿ÆÄ¿È«,¿ÉÙ¤¼±
ÒѾÓÐ4È˻ظ´
Â鷳ר¼ÒÃÇ¿´¿´ÆÀίÃǵÄÒâ¼û£¨F¿ÚÃæÉÏ£©
ÒѾÓÐ10È˻ظ´
ÃæÉÏÒâ¼û³öÀ´ÁË
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O.55.1.O.5.4,¿ÆÄ¿È«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøT0PÎÄÕ£¬ÎÒ:8.O55.1.O.54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ9È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
|